![John R. Mcdonald](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von John R. Mcdonald
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Osprey Pharmaceuticals Ltd.
![]() Osprey Pharmaceuticals Ltd. Pharmaceuticals: GenericHealth Technology Osprey Pharmaceuticals Ltd. develops a series of proprietary therapeutic drugs. Osprey Pharmaceuticals is developing a unique family of therapeutic proteins capable of treating chronic diseases. Osprey's broad technology platform is based on the critical insight that many common diseases are propagated by overabundant and overactive leukocytes. The Company's patented Leukocyte Population Modulators (LPMs) selectively and systematically remove these disease-related leukocytes by targeting the chemokine system a complex network of small proteins and their receptors that regulate the movement and activity of leukocytes. The Company's lead compound is in early clinical development for the treatment of diseases associated with chronic inflammation. Osprey also has a portfolio of preclinical LPMs that target a variety of diseases including inflammatory and immunological disorders, oncology, and cardiovascular disease. Osprey Pharmaceuticals was founded in 1997 and is located in Saint-Laurent, Canada.
6
| Extinct | Pharmaceuticals: Generic | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John R. Mcdonald
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
Applied Immune Sciences, Inc.
![]() Applied Immune Sciences, Inc. Medical SpecialtiesHealth Technology Part of Sanofi, Applied Immune Sciences, Inc. is a surgical and medical instruments company. The company is based in Menlo Park, CA. The company was founded by Thomas B. Okarma. Applied Immune Sciences was acquired by Rhone-Poulenc Rorer, Inc. on November 28, 1995 for $84.40 million. | Medical Specialties | Corporate Officer/Principal | |
Baxter Healthcare Corp.
![]() Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Medical Specialties | Corporate Officer/Principal | |
Immunex Corp.
![]() Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation | Biotechnology | Corporate Officer/Principal | |
NEKTAR THERAPEUTICS | Pharmaceuticals: Major | Corporate Officer/Principal | |
CTI BIOPHARMA CORP. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Trellis Bioscience, Inc.
![]() Trellis Bioscience, Inc. BiotechnologyHealth Technology Trellis Bioscience, Inc. is discovers and develops novel human antibody therapeutics. It provides the discovery and development of therapeutic antibodies from human B cells. The firm develops the CellSpot antibody discovery platform, which enables the identification of antibodies directly from human blood. The company was founded by Lawrence Kauvar and Stote Ellsworth in 1998 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
PRINCIPIA BIOPHARMA INC. | Pharmaceuticals: Major | Director/Board Member | |
Mosaic Biosciences, Inc.
![]() Mosaic Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Mosaic Biosciences, Inc. provides commercial research and development services. It conducts research on synthetic materials that support native tissue regeneration. The firm's solutions are designed for application in wound healing, bone regeneration, cartilage repair, stem cell therapy, and dermal fillers. The company was founded by Martin Stanton, Chris Bowman, Kristi S. Anseth and Peter Mariner in 2009 and is headquartered in Boulder, CO. | Miscellaneous Commercial Services | Director/Board Member | |
The University of Manchester | College/University | Undergraduate Degree | |
EOS Biotechnology, Inc.
![]() EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Corporate Officer/Principal | |
McGill University | College/University | Doctorate Degree | |
Newcastle University | College/University | Doctorate Degree | |
NOXXON Pharma AG
![]() NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Biotechnology | Director/Board Member | |
McMaster University | College/University | Corporate Officer/Principal | |
University of California, Santa Barbara | College/University | Undergraduate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal | |
Atugen AG
![]() Atugen AG Pharmaceuticals: MajorHealth Technology Atugen AG is a biopharmaceutical company. It develops RNAi therapeutics which focus on vivo applications in oncology and liver diseases, exploiting its proprietary oligonucleotide delivery technologies and chemically stabilized siRNA structures. Founded in 1998, the company is headquartered in Berlin, Germany | Pharmaceuticals: Major | Director/Board Member | |
Allegheny College | College/University | Undergraduate Degree | |
PDL BIOPHARMA, INC. | Biotechnology | Corporate Officer/Principal | |
PHIO PHARMACEUTICALS CORP. | Biotechnology | Director/Board Member | |
COHERUS BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
UCSF School of Medicine | College/University | Doctorate Degree | |
FORTE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
Totus Medicines, Inc.
![]() Totus Medicines, Inc. Pharmaceuticals: MajorHealth Technology Totus Medicines, Inc. manufactures drug products. The company is based in Cambridge, MA. The company was founded by Neil Dhawan, Jason Pontin. Neil Dhawan has been the CEO since incorporation. | Pharmaceuticals: Major | Chief Executive Officer | |
LifeSci Acquisition III Corp.
![]() LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Financial Conglomerates | Director/Board Member | |
Comera Life Sciences, Inc.
![]() Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million. | Pharmaceuticals: Major | Director/Board Member | |
COMERA LIFE SCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
LSV CAPITAL MANAGEMENT LLC
![]() LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management LLC (Lightstone Ventures) is a venture capital firm founded in 2012. The firm is headquartered in Menlo Park, California. | Investment Managers | Private Equity Investor |
Statistik
International
Vereinigte Staaten | 36 |
Vereinigtes Königreich | 3 |
Kanada | 3 |
Deutschland | 3 |
Sektoral
Health Technology | 28 |
Consumer Services | 9 |
Commercial Services | 5 |
Finance | 3 |
Operativ
Corporate Officer/Principal | 16 |
Director/Board Member | 16 |
President | 6 |
Chief Tech/Sci/R&D Officer | 6 |
Undergraduate Degree | 4 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Nassim Usman | 15 |
Barbara Finck | 15 |
Jack M. Anthony | 13 |
Philip J. Coggins | 4 |
Robert Wagstaff | 1 |
Hongsheng Su | 1 |
- Börse
- Insiders
- John R. Mcdonald
- Unternehmensverbindungen